- Home
- / NewLink Genetics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
NewLink Genetics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.9
2020-03-18
Market Capitalization
$33.2 M
2020-03-18
Revenue
$230 K
FY, 2021
CreditSafe Score
?
Score changed on Jun 13, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.1M | 172.6M | 68.5M | 35.8M | 28.7M | 12.5M | 936.0K | 168.0K | 230.0K | |
| Revenue growth, % | 15690.7% | -60.3% | -47.8% | |||||||
| General and administrative expense | 5.7M | 19.3M | 30.7M | 33.2M | 31.7M | 29.2M | 23.9M | 17.3M | 15.3M | |
| Operating expense total | 19.9M | 55.0M | 102.1M | 126.5M | 101.6M | 74.9M | 46.1M | |||
| EBIT | (18.1M) | (138.8M) | 117.6M | (33.6M) | (90.8M) | (72.9M) | (62.4M) | (45.1M) | (26.3M) | (31.3M) |
| EBIT margin, % | -12702.3% | 68.1% | -49.1% | -253.7% | -253.8% | -500.5% | -4822.0% | |||
| Interest income | 11.0K | 12.0K | 86.0K | 78.0K | 237.0K | 616.0K | 2.0M | 2.2M | 200.0K | 12.0K |
| Interest expense | 42.0K | 33.0K | ||||||||
| Pre tax profit | 117.6M | (33.6M) | (90.5M) | (72.5M) | (60.6M) | (43.0M) | (19.6M) | (31.1M) | ||
| Income tax expense | (130.0K) | 14.8M | 6.7M | (5.4M) | (559.0K) | (7.0M) | 12.0K | (14.0M) | (636.0K) | |
| Net Income | (18.1M) | (136.5M) | 102.9M | (40.4M) | (85.2M) | (72.0M) | (53.6M) | (43.0M) | (5.7M) | (30.4M) |